The company's principal activitity is to research, develop and commercialize innovative nuclear technologies. The company's objective is to identify, screen and develop selected technologies to the point that they may be either licensed, joint-ventured, sold to an industrial partner, or otherwise commercialized. The company's business is focused on commercial product technologies for homeland security and defense, nanotechnology applications and nuclear remediation. The company is in the development stage.
